In addition, in a reassessment involving 7855 cardiomyopathy patients and 60,706 reference samples, the team also reported that many previously identified rare variants in Ankrd1 do not exhibit the pathogenic significance initially attributed to them, further reducing its clinical relevance in cardiomyopathy [45]. The gene discussed is ANKRD1; the disease is cardiomyopathy.